Natamycin interferes with ergosterol-dependent lipid phases in model membranes

Natamycin is an antifungal polyene macrolide that is used as a food preservative but also to treat fungal keratitis and other yeast infections. In contrast to other polyene antimycotics, natamycin does not form ion pores in the plasma membrane, but its mode of action is poorly understood. Using nucl...

Full description

Bibliographic Details
Main Authors: Vibeke Akkerman, Holger A. Scheidt, Peter Reinholdt, Mohammad Bashawat, Maria Szomek, Max Lehmann, Pablo Wessig, Douglas F. Covey, Jacob Kongsted, Peter Müller, Daniel Wüstner
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:BBA Advances
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667160323000315
_version_ 1797405282815442944
author Vibeke Akkerman
Holger A. Scheidt
Peter Reinholdt
Mohammad Bashawat
Maria Szomek
Max Lehmann
Pablo Wessig
Douglas F. Covey
Jacob Kongsted
Peter Müller
Daniel Wüstner
author_facet Vibeke Akkerman
Holger A. Scheidt
Peter Reinholdt
Mohammad Bashawat
Maria Szomek
Max Lehmann
Pablo Wessig
Douglas F. Covey
Jacob Kongsted
Peter Müller
Daniel Wüstner
author_sort Vibeke Akkerman
collection DOAJ
description Natamycin is an antifungal polyene macrolide that is used as a food preservative but also to treat fungal keratitis and other yeast infections. In contrast to other polyene antimycotics, natamycin does not form ion pores in the plasma membrane, but its mode of action is poorly understood. Using nuclear magnetic resonance (NMR) spectroscopy of deuterated sterols, we find that natamycin slows the mobility of ergosterol and cholesterol in liquid-ordered (Lo) membranes to a similar extent. This is supported by molecular dynamics (MD) simulations, which additionally reveal a strong impact of natamycin dimers on sterol dynamics and water permeability. Interference with sterol-dependent lipid packing is also reflected in a natamycin-mediated increase in membrane accessibility for dithionite, particularly in bilayers containing ergosterol. NMR experiments with deuterated sphingomyelin (SM) in sterol-containing membranes reveal that natamycin reduces phase separation and increases lipid exchange in bilayers with ergosterol. In ternary lipid mixtures containing monounsaturated phosphatidylcholine, saturated SM, and either ergosterol or cholesterol, natamycin interferes with phase separation into Lo and liquid-disordered (Ld) domains, as shown by NMR spectroscopy. Employing the intrinsic fluorescence of natamycin in ultraviolet-sensitive microscopy, we can visualize the binding of natamycin to giant unilamellar vesicles (GUVs) and find that it has the highest affinity for the Lo phase in GUVs containing ergosterol. Our results suggest that natamycin specifically interacts with the sterol-induced ordered phase, in which it disrupts lipid packing and increases solvent accessibility. This property is particularly pronounced in ergosterol containing membranes, which could underlie the selective antifungal activity of natamycin.
first_indexed 2024-03-09T03:07:35Z
format Article
id doaj.art-041ec6aab4b0418b99b133f0163d9c86
institution Directory Open Access Journal
issn 2667-1603
language English
last_indexed 2024-03-09T03:07:35Z
publishDate 2023-01-01
publisher Elsevier
record_format Article
series BBA Advances
spelling doaj.art-041ec6aab4b0418b99b133f0163d9c862023-12-04T05:24:56ZengElsevierBBA Advances2667-16032023-01-014100102Natamycin interferes with ergosterol-dependent lipid phases in model membranesVibeke Akkerman0Holger A. Scheidt1Peter Reinholdt2Mohammad Bashawat3Maria Szomek4Max Lehmann5Pablo Wessig6Douglas F. Covey7Jacob Kongsted8Peter Müller9Daniel Wüstner10Department of Biochemistry and Molecular Biology, University of Southern Denmark, DK-5230, Odense M, DenmarkInstitute for Medical Physics and Biophysics, Leipzig University, Härtelstr. 16-18, D-04107, Leipzig, GermanyDepartment of Physics, Chemistry and Pharmacy, University of Southern Denmark, DK-5230, Odense M, DenmarkDepartment of Biology, Humboldt University Berlin, Invalidenstr. 43, D-10115, Berlin, GermanyDepartment of Biochemistry and Molecular Biology, University of Southern Denmark, DK-5230, Odense M, DenmarkInstitute for Chemistry, University of Potsdam, Karl-Liebknecht-Str. 24-25, D-14476, Potsdam, GermanyInstitute for Chemistry, University of Potsdam, Karl-Liebknecht-Str. 24-25, D-14476, Potsdam, GermanyDepartment of Developmental Biology, Washington University, St. Louis, MO, 63110, USA; Taylor Family Institute for Innovative Psychiatric Research, St. Louis, Missouri, USADepartment of Physics, Chemistry and Pharmacy, University of Southern Denmark, DK-5230, Odense M, DenmarkDepartment of Biology, Humboldt University Berlin, Invalidenstr. 43, D-10115, Berlin, GermanyDepartment of Biochemistry and Molecular Biology, University of Southern Denmark, DK-5230, Odense M, Denmark; Corresponding author at: Department of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, DK-5230, Odense M, Denmark.Natamycin is an antifungal polyene macrolide that is used as a food preservative but also to treat fungal keratitis and other yeast infections. In contrast to other polyene antimycotics, natamycin does not form ion pores in the plasma membrane, but its mode of action is poorly understood. Using nuclear magnetic resonance (NMR) spectroscopy of deuterated sterols, we find that natamycin slows the mobility of ergosterol and cholesterol in liquid-ordered (Lo) membranes to a similar extent. This is supported by molecular dynamics (MD) simulations, which additionally reveal a strong impact of natamycin dimers on sterol dynamics and water permeability. Interference with sterol-dependent lipid packing is also reflected in a natamycin-mediated increase in membrane accessibility for dithionite, particularly in bilayers containing ergosterol. NMR experiments with deuterated sphingomyelin (SM) in sterol-containing membranes reveal that natamycin reduces phase separation and increases lipid exchange in bilayers with ergosterol. In ternary lipid mixtures containing monounsaturated phosphatidylcholine, saturated SM, and either ergosterol or cholesterol, natamycin interferes with phase separation into Lo and liquid-disordered (Ld) domains, as shown by NMR spectroscopy. Employing the intrinsic fluorescence of natamycin in ultraviolet-sensitive microscopy, we can visualize the binding of natamycin to giant unilamellar vesicles (GUVs) and find that it has the highest affinity for the Lo phase in GUVs containing ergosterol. Our results suggest that natamycin specifically interacts with the sterol-induced ordered phase, in which it disrupts lipid packing and increases solvent accessibility. This property is particularly pronounced in ergosterol containing membranes, which could underlie the selective antifungal activity of natamycin.http://www.sciencedirect.com/science/article/pii/S2667160323000315Polyene macrolideYeastAntifungalsErgosterolCholesterolLipid phase
spellingShingle Vibeke Akkerman
Holger A. Scheidt
Peter Reinholdt
Mohammad Bashawat
Maria Szomek
Max Lehmann
Pablo Wessig
Douglas F. Covey
Jacob Kongsted
Peter Müller
Daniel Wüstner
Natamycin interferes with ergosterol-dependent lipid phases in model membranes
BBA Advances
Polyene macrolide
Yeast
Antifungals
Ergosterol
Cholesterol
Lipid phase
title Natamycin interferes with ergosterol-dependent lipid phases in model membranes
title_full Natamycin interferes with ergosterol-dependent lipid phases in model membranes
title_fullStr Natamycin interferes with ergosterol-dependent lipid phases in model membranes
title_full_unstemmed Natamycin interferes with ergosterol-dependent lipid phases in model membranes
title_short Natamycin interferes with ergosterol-dependent lipid phases in model membranes
title_sort natamycin interferes with ergosterol dependent lipid phases in model membranes
topic Polyene macrolide
Yeast
Antifungals
Ergosterol
Cholesterol
Lipid phase
url http://www.sciencedirect.com/science/article/pii/S2667160323000315
work_keys_str_mv AT vibekeakkerman natamycininterfereswithergosteroldependentlipidphasesinmodelmembranes
AT holgerascheidt natamycininterfereswithergosteroldependentlipidphasesinmodelmembranes
AT peterreinholdt natamycininterfereswithergosteroldependentlipidphasesinmodelmembranes
AT mohammadbashawat natamycininterfereswithergosteroldependentlipidphasesinmodelmembranes
AT mariaszomek natamycininterfereswithergosteroldependentlipidphasesinmodelmembranes
AT maxlehmann natamycininterfereswithergosteroldependentlipidphasesinmodelmembranes
AT pablowessig natamycininterfereswithergosteroldependentlipidphasesinmodelmembranes
AT douglasfcovey natamycininterfereswithergosteroldependentlipidphasesinmodelmembranes
AT jacobkongsted natamycininterfereswithergosteroldependentlipidphasesinmodelmembranes
AT petermuller natamycininterfereswithergosteroldependentlipidphasesinmodelmembranes
AT danielwustner natamycininterfereswithergosteroldependentlipidphasesinmodelmembranes